Skeletal Muscle Cancer in Dogs (Rhabdomyosarcoma)

Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Rhabdomyosarcoma is a rare form of soft tissue cancer that develops in the musculature of dogs. This type of tumor is malignant and can spread quickly, making early diagnosis and treatment crucial.

The most important facts at a glance

Rhabdomyosarcomas are malignant tumors that arise from cells responsible for the formation of muscle tissue. These tumors are aggressive and can spread to various parts of the body. While they occur rarely in dogs, they represent a serious health problem. The exact causes of their development are not fully understood, but genetic factors and possibly environmental factors play a role. Common symptoms are soft, diffuse masses in the musculature, muscle weakness, and lameness. A diagnosis requires a thorough examination and often imaging procedures as well as a biopsy of the tumor.

The treatment of rhabdomyosarcomas is complex and usually includes a combination of surgery, radiation therapy, and chemotherapy. Surgical removal of the tumor is often the first choice, followed by additional therapies to combat remaining tumor cells. The prognosis depends on many factors, including the size and location of the tumor as well as the presence of metastases. Despite intensive treatment, there is a significant risk of recurrence. Preventive measures are limited, but a healthy lifestyle and regular veterinary examinations can help promote the dog’s overall well-being and detect possible health problems early.

Causes

Rhabdomyosarcomas arise from mesenchymal cells responsible for the formation of muscle tissue. These tumors are malignant, meaning they can invade surrounding tissue and spread to other parts of the body. The exact origin of these tumors is not yet fully understood, but they appear to arise from cells that were maldeveloped during embryogenesis.

While rhabdomyosarcomas are rare in dogs, they are still a significant problem because they are aggressive and have a poor prognosis. The tumors can occur in various muscles of the body, but most commonly in the muscles of the limbs or head. There are different subtypes of rhabdomyosarcomas, including embryonal, alveolar, and pleomorphic types, each of which can have different characteristics and courses.

The causes of rhabdomyosarcoma development in dogs are not fully understood. Genetic factors likely play a role, as an increased predisposition is observed in some dog breeds. Environmental factors and exposure to certain chemicals could also contribute to the development of these tumors, although this has not yet been conclusively proven.

Genetic mutations occurring in tumor cells are frequently associated with the development of rhabdomyosarcomas. These mutations can occur spontaneously or be triggered by external factors. Studies suggest that certain genetic abnormalities such as chromosomal aberrations and gene fusions may play a role in the development of these tumors.

Symptoms

The symptoms of rhabdomyosarcomas in dogs depend largely on the location and size of the tumor. Common signs are swelling or lumps that are palpable under the skin, particularly near the limbs or on the head. These lumps may or may not be painful, depending on whether they press on nerves or other sensitive tissue.

Additional symptoms may include lameness or difficulty moving, especially when the tumor is located near joints or in the limbs. Dogs may also show signs of general malaise, loss of appetite, or weight loss, especially when the tumor progresses and spreads to other parts of the body.

In advanced stages, systemic symptoms may occur, such as lethargy, weakness, and anemia, as the tumor consumes the body’s resources or impairs blood production. Respiratory distress may occur when the tumor puts pressure on the airways or metastases have formed in the lungs.

Diagnosis

The diagnosis of rhabdomyosarcoma typically begins with a thorough physical examination by a veterinarian. The dog is examined for noticeable lumps or swelling. If a tumor is suspected, further diagnostic steps are necessary to determine the type of tumor.

Imaging procedures such as X-rays, ultrasound, or magnetic resonance imaging (MRI) can be used to determine the exact location and extent of the tumor. These procedures also help determine whether the tumor has metastasized to other areas of the body.

A biopsy is the gold standard for diagnosing rhabdomyosarcomas. A tissue sample of the tumor is taken and examined under a microscope. This examination allows analysis of the cellular structure of the tumor and determination of its type. Immunohistochemical staining and genetic tests can provide additional information about the molecular composition of the tumor.

Therapy

The treatment of rhabdomyosarcomas in dogs is complex and often requires a multimodal approach. Surgical removal of the tumor is usually the first treatment option, especially when the tumor is well-defined and operable. The goal of surgery is to completely remove the tumor to minimize the risk of recurrence.

In addition to surgery, radiation therapy may be used, particularly when the tumor could not be completely removed or when it is located in a difficult-to-access area. Radiation therapy can help kill remaining tumor cells and control tumor growth.

Chemotherapy may also be part of the treatment plan, especially for aggressive or metastatic tumors. Various chemotherapy agents can be used to inhibit tumor growth and improve the dog’s quality of life. The choice of medications depends on the type of rhabdomyosarcoma and the dog’s overall health condition.

Prognosis and follow-up care

The prognosis for dogs with rhabdomyosarcoma varies greatly and depends on several factors, including the size and location of the tumor, the presence of metastases, and the response to treatment. In general, the prognosis is better with early diagnosis and aggressive therapy.

However, rhabdomyosarcomas are often difficult to treat because they tend to grow and spread quickly. Even with combined treatment of surgery, radiation therapy, and chemotherapy, there is a significant risk of recurrence or the development of metastases.

The average survival time after diagnosis varies but can be several months to a year or longer with successful treatment. Close follow-up care is crucial to detect possible relapses early and take appropriate action.

Prevention

Since the exact causes of rhabdomyosarcomas are not fully understood, there are no specific preventive measures to prevent these tumors in dogs. However, general health care and regular veterinary examinations can help detect potential health problems early.

A balanced diet, regular exercise, and a healthy lifestyle can help promote the dog’s overall well-being and health, potentially reducing the risk of developing cancer. Avoiding known carcinogens and minimizing exposure to environmental toxins could also be helpful.

For breeds that may have a genetic predisposition to rhabdomyosarcomas, it may be advisable to carefully reconsider breeding decisions. Genetic counseling and the selection of healthy breeding animals could help reduce the risk of developing these tumors in future generations.

Frequently asked questions (FAQs)

1. What is a rhabdomyosarcoma?
A rhabdomyosarcoma is a malignant soft tissue tumor arising from striated muscle. It belongs to the soft tissue sarcomas but behaves more aggressively than many other sarcomas and frequently metastasizes. The tumor preferentially occurs at the head, oral cavity, urinary bladder and skeletal muscle.
2. Which dogs are affected?
Rhabdomyosarcomas occur in dogs of any age but are more common in younger animals under two years of age. There is no clear breed predisposition; St. Bernards and other large breeds are slightly overrepresented. Embryonal rhabdomyosarcoma of the bladder is described in young dogs.
3. What symptoms does an affected dog show?
Symptoms depend on location. Limb tumors cause swellings and lameness; oral tumors lead to eating problems, bleeding and bad breath. Bladder rhabdomyosarcomas present with bloody urine, painful urination and incontinence.
4. How is the diagnosis made?
Fine-needle aspiration provides initial clues, but definitive diagnosis requires histology and immunohistochemistry with muscle-specific markers (desmin, myoglobin, MyoD1). Staging includes CT/MRI of the affected region as well as evaluation of lymph nodes and the thorax to rule out metastases.
5. How is rhabdomyosarcoma treated?
Treatment is multimodal. Surgical removal with wide margins is the foundation. Radiation therapy is added for tumors that cannot be fully resected. Chemotherapy with doxorubicin, vincristine and cyclophosphamide may be used in cases at high risk of metastasis or with residual tumor.
6. How high is the risk of metastasis?
The risk is substantial and depends on the histologic subtype. Pulmonary metastases occur in many patients, and regional lymph nodes are also frequently involved. Careful staging and regular follow-up are therefore essential.
7. What is the prognosis?
Overall, the prognosis is guarded. With complete resection of small superficial tumors without metastases, median survival times of 12 to 24 months are achievable. With metastasis or incomplete resection, survival is usually only a few months.
8. How does it differ from other soft tissue sarcomas?
Classic soft tissue sarcomas such as fibrosarcoma or malignant fibrous histiocytoma grow locally invasively but rarely metastasize. Rhabdomyosarcoma, in contrast, has a much higher metastatic potential and requires systemic therapy. Immunohistochemistry is essential for the distinction.
9. What role does follow-up play?
Because of the high recurrence and metastatic risk, close follow-up is required. Clinical examination every two months, imaging of the surgical region, thoracic radiographs or CT and lymph node evaluation every three months are recommended for the first two years.
10. Is there an option for early detection?
There is no general screening program. What matters is paying attention to new swellings, especially in young dogs, and obtaining early biopsies of any unclear muscle mass. The earlier the diagnosis, the better the chances of effective treatment.